Monthly Archives: June 2016

GKA shows improved type 2 glyceamic control

14th June 2016

A new type of liver-selective glucokinase activator (GKA) has shown improved glyceamic control and insulin resistance in people with type 2 diabetes. At the American Diabetes Association‘s ...

Read more

Diabetes figures in Wales soar

14th June 2016

A diabetes “crisis” has descended upon Wales with more people in the country living with the condition than ever before, according to a health charity.   Diabetes UK Cymru said 7.1 ...

Read more

Novo publishes positive Victoza® results

14th June 2016

The GLP-1 receptor analogue Victoza® (liraglutide) significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial, Novo Nordisk has ...

Read more

Tresiba significantly lowers hypo rates

13th June 2016

New results from two Phase 3b trials have shown people with type 1 and type 2 diabetes  treated with Tresiba® (insulin degludec) experienced significantly lower rates of several types of ...

Read more

Major rise in type 2 diabetes over 12 months

13th June 2016

Almost a quarter of a million people have been diagnosed with diabetes in the last year largely down to a rise in type 2, Diabetes UK has announced. The charity has published the figures – which ...

Read more

Novo publishes hypo resources

13th June 2016

A new resource hub has been released by Novo Nordisk to support people with diabetes. It has been created to help people to better understand the often misunderstood signs and long-term impact of ...

Read more